In addition to its association with MASLD, some prospective studies have also suggested that PNPLA3 variants are associated with chronic kidney disease [25], and patients carrying PNPLA3 variants have a higher risk of early glomerular and tubular damage [26]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.